Sydney Lupkin
speaker
1,087 appearances
111 recordings
3 series
first heard Dec 2024
last heard 4d ago
Sydney Lupkin’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsRecordings per month over the last 12 months — 96 in all, peaking in Sep 2026 with 23.
Appearances
That means people without coverage will have to pay the full sticker price for the name brand drugs, and that's unaffordable for a lot of people who've turned to the cheaper compounded versions of the drugs.
Some are stockpiling the compounded drugs, you know, while they can. I checked in with Mary Struski, an Arizona woman who told me a few weeks ago about how she lost 50 pounds so far on compounded terzepatide. She says she and her nurse practitioner settled on a plan to buy enough terzepatide to get her through until about April.
And after that, she isn't sure, but she says she needs to find a way to keep taking the medicine.
Her health is better, and she says she's free of the anxiety that came with eating. She's thinking about what she wants to accomplish in 2025.
You know, it could because the FDA just approved ZepBound as the first drug treatment for moderate to severe obstructive sleep apnea in patients who have obesity. Obstructive sleep apnea is a condition in which someone temporarily pauses breathing in their sleep because their upper airway collapses. It is more common among people who have obesity.
The new approval could open the door for ZEP-bound coverage by Medicare and Medicaid because it's not just a weight loss drug anymore. So while that's not going to solve everyone's insurance problems here, it could help a lot of people.
You bet.
Showing 1081–1087 of 1,087 · page 55 of 55
← Previous